Division of Drug Informatics, Keio University Faculty of Pharmacy.
Department of Pharmacy, Kanagawa Prefectural Keiyukai Keiyu Hospital.
Biol Pharm Bull. 2024;47(8):1460-1466. doi: 10.1248/bpb.b24-00365.
Dispensing errors pose a significant health risk, with drug name similarity being a potential contributory factor. To determine the impact of drug name similarity on dispensing errors within clinical settings, we analyzed 563 dispensing errors at an acute hospital in Japan from April 2015 to June 2018. Drug name similarity between two drugs was classified into Name-Similar and Name-Dissimilar groups using the m2-vwhtfrag index, the value of the drug name similarity. Drug efficacy similarity was categorized into Efficacy-Same, Efficacy-Close, and Efficacy-Far. The drug name similarity and drug efficacy similarity of all possible pair combinations were obtained and similarly classified. The proportion of the number of pairs with dispensing errors per the total number of drug pairs in the hospital's drug formulary in each category was calculated. The highest proportion of the number of pairs with dispensing errors was 36% for the Efficacy-Same and Name-Similar group, and the lowest proportion was 0.022% for the Efficacy-Far and Name-Dissimilar group. The proportion of the number of pairs with dispensing errors was significantly higher in the Name-Similar category than in the Name-Dissimilar category for all drug efficacy categories. Our results indicate that drug name similarity increases the risk of dispensing errors, and that m2-vwhtfrag is a useful indicator to assess dispensing errors in clinical practice. Such drug name and efficacy similarity evaluations can help identify factors causing dispensing errors, and predict the risk of dispensing errors for newly adopted drugs, considering the relationship with the whole drug formulary in the hospital dispensary.
调配错误对健康构成重大风险,而药物名称相似性是一个潜在的促成因素。为了确定药物名称相似性对临床环境中调配错误的影响,我们分析了日本一家急症医院 2015 年 4 月至 2018 年 6 月期间发生的 563 例调配错误。使用 m2-vwhtfrag 指数(药物名称相似性的值)将两种药物的药物名称相似性分为 Name-Similar 和 Name-Dissimilar 组。药物疗效相似性分为 Efficacy-Same、Efficacy-Close 和 Efficacy-Far。获得并类似地分类了所有可能的药物对组合的药物名称相似性和药物疗效相似性。计算了每个类别中具有调配错误的药物对数量与医院药物处方总数的比例。Efficacy-Same 和 Name-Similar 组中具有调配错误的药物对数量的比例最高,为 36%,Efficacy-Far 和 Name-Dissimilar 组中具有调配错误的药物对数量的比例最低,为 0.022%。对于所有药物疗效类别,Name-Similar 类别中具有调配错误的药物对数量的比例明显高于 Name-Dissimilar 类别。我们的结果表明,药物名称相似性增加了调配错误的风险,并且 m2-vwhtfrag 是评估临床实践中调配错误的有用指标。这种药物名称和疗效相似性评估可以帮助识别导致调配错误的因素,并预测新采用的药物的调配错误风险,同时考虑到与医院药房中整个药物处方的关系。